(Q37785241)

23 August 2017

title

Heritability of hematologic malignancies: from pedigrees to genomics (English)

1 reference

23 August 2017

Heritability of Hematologic Malignancies: From Pedigrees to Genomics (English)

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

6 July 2024

1 reference

1 reference

Kenan Onel

2

1 reference

23 August 2017

Jane E. Churpek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816581

6 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816581

6 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0889858810000900?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

https://api.elsevier.com/content/article/PII:S0889858810000900?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Hematology / Oncology Clinics of North America

6 July 2024

published in

1 reference

23 August 2017

volume

24

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

939-972

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

23 August 2017

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Familial (inherited) leukemia, lymphoma, and myeloma: an overview

1

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The genetics of familial leukemia

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial Leukaemia: A Study of 909 Families

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Chronic lymphocytic leukemia in a family, including twin brothers and a son

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial chronic lymphocytic leukemia

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

CLL family ‘Pedigree 14’ revisited: 1947–2004

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Analysis of a large multi-generational family provides insight into the genetics of chronic lymphocytic leukemia

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A genome scan of 18 families with chronic lymphocytic leukaemia

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

High-density mapping and follow-up studies on chromosomal regions 1, 3, 6, 12, 13 and 17 in 28 families with chronic lymphocytic leukaemia.

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genomic aberrations and survival in chronic lymphocytic leukemia

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Epigenetics in chronic lymphocytic leukemia

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: the CUMAGAS-CLL information system

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The molecular basis of familial chronic lymphocytic leukemia

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The role of microRNA in human leukemia: a review

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Causes and consequences of microRNA dysregulation in cancer

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

6 July 2024

How I treat CLL up front

35

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial aggregation of Hodgkin lymphoma and related tumors

6 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A cohort study of cancer risk in relation to family histories of cancer in the Utah population database

6 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease

6 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Hodgkin's disease in siblings

6 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Incidence of familial Hodgkin's disease

6 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database

6 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4.

6 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Pseudoautosomal linkage of Hodgkin disease

6 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Further evidence for a pseudoautosomal gene for Hodgkin's lymphoma: Reply to 'The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database' by Altieri A and Hemminki K.

6 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Pseudoautosomal linkage of familial Hodgkin's lymphoma: molecular analysis of a unique family with Leri-Weill dyschondrosteosis and Hodgkins lymphoma

6 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Analysis of major histocompatibility complex class I expression on Reed- Sternberg cells in relation to the cytotoxic T-cell response in Epstein- Barr virus-positive and -negative Hodgkin's disease

6 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region

6 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease

6 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

6 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma

6 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma

6 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

6 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients

6 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells

6 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery

6 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

6 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The non-Hodgkin lymphomas: a review of the epidemiologic literature

6 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma

6 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risk of cancer in migrants and their descendants in Israel: I. Leukaemias and lymphomas.

6 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia

6 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Cancer mortality in African and Caribbean migrants to England and Wales.

6 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

6 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

6 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Highly increased familial risks for specific lymphoma subtypes

6 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes

6 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations

6 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland

6 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies

6 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma

6 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The genetics of familial lymphomas

6 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in theMSH2 gene

6 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic susceptibility to lymphoma

6 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk

6 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

6 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma

6 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

6 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study

6 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Common genetic variants in candidate genes and risk of familial lymphoid malignancies

6 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma

6 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A Putative Exonic Splicing Polymorphism in the BCL6 Gene and the Risk of Non-Hodgkin Lymphoma

6 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development

6 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies

6 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma

6 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A functional TNFRSF5 gene variant is associated with risk of lymphoma

6 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

6 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial Waldenstrom's macroglobulinemia

6 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

6 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families

6 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis

6 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

6 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Initial report of a family registry of multiple myeloma.

6 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study

6 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden

6 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.

6 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

6 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

6 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Phenotypic heterogeneity in multiple myeloma families

6 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial multiple myeloma. A review of thirty-seven families

6 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial multiple myeloma: report of fifteen families

6 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Anticipation in familial plasma cell dyscrasias

6 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance

6 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study

6 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

6 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial myeloproliferative disease

6 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial myeloproliferative syndrome.

6 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease

6 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

6 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A gain-of-function mutation of JAK2 in myeloproliferative disorders

6 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

6 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The genetic basis of myeloproliferative disorders

6 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

6 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Letter: Tinel sign in carpal-tunnel syndrome.

6 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation

6 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden

6 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

6 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

6 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

6 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

6 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

6 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Mutation in TET2 in myeloid cancers

6 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

6 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Disease anticipation in familial myeloproliferative neoplasms

6 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Leukemia in twins: lessons in natural history

6 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database

6 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome

6 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

6 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

6 July 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

6 July 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

6 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray

6 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

6 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia

6 July 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia

6 July 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia.

6 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia.

6 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Perforin A91V polymorphism and putative susceptibility to hematological malignancies

6 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population

6 July 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

6 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Germline genomic variants associated with childhood acute lymphoblastic leukemia

6 July 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002.

6 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial myelodysplasia and acute myeloid leukaemia--a review

6 July 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Inherited aplastic anaemias/bone marrow failure syndromes

6 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

6 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

6 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

6 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome

6 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

6 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

6 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia

6 July 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation

6 July 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Mutation of CEBPA in familial acute myeloid leukemia

6 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

6 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Chromosome band 16q22-linked familial AML: exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms

6 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Familial partial monosomy 7 and myelodysplasia

6 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

6 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia

6 July 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

6 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Recurring mutations found by sequencing an acute myeloid leukemia genome

6 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Therapy-related myeloid leukemia.

6 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia

6 July 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genetic predisposition and treatment-related leukemia

6 July 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1

6 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia

6 July 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

6 July 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia

6 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia

6 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility

6 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genome scan implicates adhesion biological pathways in secondary leukemia

6 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility

6 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Neurofibromatosis type 1 and associated malignancies.

6 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

6 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations

6 July 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Cancer in dyskeratosis congenita

6 July 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report

6 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry

6 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Bloom's syndrome. XX. The first 100 cancers

6 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome

6 July 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Aplastic anemia in a patient with Rothmund-Thomson syndrome

6 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group

6 July 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease

6 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.

6 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

The many causes of severe congenital neutropenia

6 July 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Down syndrome and acute lymphoblastic leukaemia

6 July 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

A multiinstitutional survey of the Wiskott-Aldrich syndrome.

6 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

Injury prevention counseling by pediatricians: a benefit-cost comparison

6 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.001

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference